Investigational Site Number : 6160002

Lodz 93-530

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Completed
• Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis — Completed